Prevention of injuries in adult recreational runners Injury, Occupational Diseases, Poisoning
Conditions
Interventions
This is a three-arm, randomized controlled trial designed in accordance with the CONSORT statement guidelines. The study will include two intervention periods: (1) May–October 2021 (n=150)
and (2) May–October 2022 (n=150). 150 participants will be recruited for each intervention period. Participants will be randomized into three groups: intervention 1 (IG1), intervention 2 (IG2), and th
Sponsors
Urho Kaleva Kekkonen Institute for Health Promotion Research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18–55 years of age 2. Less than 2 years of weekly running exposure 3. Running is the primary form of exercise 4. No musculoskeletal injuries within 3 months at the time of study onset 5. No major surgery to the lower extremities within the previous 6 months 6. No history of systemic disease (e.g., cardiac disease) or neurological disorder (e.g., concussion) 7. No history of bone fracture in the spine, pelvis or lower extremity in the past year 8. Final participation will be based on the informed consent of each individual runner
Exclusion criteria
Exclusion criteria: 1. Younger than 18 or older than 55 at the time of recruitment 2. More than two years of weekly running exposure 3. Running is not the primary form of exercise 4. History of musculoskeletal injury within 3 months at the time of study onset 5. History of surgery to the lower extremities within 6 months at the time of study onset 6. History of systemic or neurological disorder that might influence the outcome 7. History of bone fracture in the spine, pelvis or lower extremity in the past year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Running-related lower extremity injuries measured using a validated Oslo Sports Trauma Research Centre Injury questionnaire (OSTRC-Q) every week for the duration of the study. In addition, a study physiotherapist will interview each injured player using a validated Injury Report Form (IRF) including questions of time and place of occurrence, cause, type, location and severity of the injury. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Performance measures, such as kinematics and kinetics during running, strength of hip, knee and ankle muscles, and single-leg balance: 1.1. Running kinematics and kinetics measured using three-dimensional motion analysis (Vicon) at baseline and at the end of the intervention period 1.2. Isokinetic strength of lower extremity muscles measured using an isokinetic dynamometer (Biodex) at baseline and at the end of the intervention period 1.3. Single leg postural stability measured using a balance platform (Metitur) at baseline and at the end of the intervention period 2. Adherence to NMT training documented using an attendance form including the date and duration of the session, exercises completed and participation of each participant, after each session 3. Knowledge, attitudes and beliefs to injury prevention measured using a structured questionnaire (7-point Likert scale) prior to and at the end of the intervention period 4. Adoption and maintenance of injury prevention training measured using a structured questionnaire at 6 months and 12 months after the end of the intervention period, including questions about the utilization of the injury prevention training program, possible modifications of program/exercises, as well as perceived advantages, disadvantages of the program, and challenges and barriers of using the program in their everyday training. 5. Physical activity, sedentary behaviour and sleep measured using a tri-axial accelerometer for seven consecutive days and nights 6. Maximal oxygen uptake measured using a treadmill test (breath by breath expired VO2 and VCO2, blood lactate, and RR intervals collected continuously during the test) at the baseline and at the end of the intervention 7. Heart rate variability (HRV) measured using an HRV recording device (Firstbeat Bodyguard) at baseline and the end of the intervention. Participants will be asked to wear the device for about 2 hours (length of performance testing session) | — |
Countries
Canada, Finland
Outcome results
None listed